Moreover, lysoSM strongly inhibits the proliferation of MDA-MB-435S breast cancer cells by regulating the Hippo-signaling pathway, causing an up-regulation of the tumor suppressive kinase Lats2 via S1P receptor 2 (S1P2) and Akt inhibition [75]. This evidence concerns the gene S1PR2 and breast cancer.